Humira-cd/uc/hs Starter Coupons & Savings Card – Discount Prices from $3584.85
My prescription
Edit
40MG/0.8ML, Humira-cd/uc/hs Starter (1 Auto-injector Kit)
Select pharmacy
Walgreens
$3584.85
COUPON PRICE
Albertsons
$20943.59
COUPON PRICEHumira-cd/uc/hs Starter savings card
Show this card to your pharmacistWalgreens
$3584.85
BIN
ID
PCN
GRP
019876
LH3D7F4711
CHIPPO
LHX
Powered by
Price history for Humira-cd/uc/hs Starter
1 Auto-injector Kit, 40MG/0.8ML
Average retail price for Humira-cd/uc/hs Starter
Average SaveHealth price for Humira-cd/uc/hs Starter
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Humira-cd/uc/hs Starter dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 40MG/0.8ML | 1 Auto-injector Kit | $3584.85 | $3584.85 |
| 80MG/0.8ML | 1 Auto-injector Kit | $7177.71 | $7177.71 |
Humira-cd/uc/hs Starter Warnings
When considering Humira (adalimumab) for the treatment of Crohn's disease, ulcerative colitis, or hidradenitis suppurativa, it's important to be aware of certain risks associated with its use:
Serious Infections: Humira can lower your immune system's ability to fight infections, increasing the risk of serious infections such as tuberculosis (TB) and other bacterial, viral, or fungal infections. Some of these infections have been fatal. Before starting Humira, your doctor should test you for TB and monitor you for signs of infection during treatment. If you develop a serious infection, Humira should be discontinued.
Cancer Risk: There have been reports of certain types of cancer, including lymphoma and skin cancers, in patients using TNF blockers like Humira. Some cases of a rare and serious type of lymphoma called hepatosplenic T-cell lymphoma have been observed, particularly in adolescents and young adults with inflammatory bowel disease. Discuss your individual risk factors with your doctor before starting treatment.
Hepatitis B Virus Reactivation: If you are a carrier of hepatitis B virus (HBV), using Humira may increase the risk of reactivating the virus, which can be serious or even fatal. Your doctor should evaluate you for HBV before initiating treatment and monitor you during and after therapy.
Neurologic Reactions: Rare cases of new or worsening central nervous system disorders, such as multiple sclerosis, optic neuritis, and Guillain-Barré syndrome, have been reported in patients using TNF blockers like Humira. If you experience symptoms like vision problems, weakness, or numbness, inform your doctor immediately.
Heart Failure: Humira has been associated with new onset or worsening of congestive heart failure (CHF). If you have a history of heart failure, your doctor should monitor you closely during treatment.
Autoimmune Reactions: In some cases, treatment with Humira has led to the development of lupus-like syndrome. Symptoms may include chest discomfort, shortness of breath, joint pain, or a rash on your cheeks or arms that worsens with sun exposure. If these occur, contact your doctor promptly.
Before starting Humira, discuss these risks with your healthcare provider to determine if this treatment is appropriate for you.
Humira-cd/uc/hs Starter Side Effects
When beginning treatment with Humira for conditions such as Crohn's disease, ulcerative colitis, or hidradenitis suppurativa, it's important to be aware of potential side effects associated with the initial doses. Common side effects include reactions at the injection site, such as pain, redness, rash, swelling, itching, or bruising. These reactions are typically mild and tend to resolve within a few days. Other frequently reported side effects are upper respiratory infections (like sinus infections), headaches, rash, and nausea. In addition to these common side effects, Humira can increase the risk of serious infections, including tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some individuals have experienced severe infections that required hospitalization. It's crucial to inform your doctor if you have any signs of infection, such as fever, cough, or flu-like symptoms, before starting Humira. Your doctor should test you for TB before initiating treatment and monitor you closely for signs and symptoms of TB during therapy, even if your initial TB test was negative. There is also an increased risk of certain types of cancer, including lymphoma and skin cancers, in patients using TNF blockers like Humira. Some cases of a rare type of cancer called hepatosplenic T-cell lymphoma have been reported, particularly in adolescents and young adults with Crohn's disease or ulcerative colitis. Discuss any concerns about cancer risks with your doctor before starting treatment. Other serious side effects may include liver problems, heart failure, nervous system issues, and blood disorders. Symptoms to watch for include yellowing of the skin or eyes, shortness of breath, numbness or tingling, and unusual bruising or bleeding. If you experience any of these symptoms, contact your healthcare provider immediately. It's essential to have open communication with your doctor about any side effects you experience while on Humira. They can provide guidance on managing side effects and determine whether any adjustments to your treatment plan are necessary.
Humira-cd/uc/hs Starter Interactions
When starting Humira (adalimumab) for conditions like Crohn's disease, ulcerative colitis, or hidradenitis suppurativa, it's crucial to be aware of potential interactions with other medications and treatments. Combining Humira with certain drugs can increase the risk of serious infections or other adverse effects. Here are key considerations:
Biologic Disease-Modifying Antirheumatic Drugs (DMARDs): Using Humira alongside other biologic DMARDs, such as anakinra or abatacept, is not recommended. This combination may elevate the risk of serious infections without providing additional therapeutic benefits.
Other Tumor Necrosis Factor (TNF) Blockers: Concurrent use of Humira with other TNF blockers like infliximab or etanercept should be avoided, as it can heighten the likelihood of adverse effects.
Live Vaccines: Patients on Humira should not receive live vaccines. The medication can weaken the immune system, making live vaccines potentially unsafe.
Corticosteroids and Immunosuppressants: Combining Humira with corticosteroids (e.g., Prednisone) or other immunosuppressants may further suppress the immune system, increasing susceptibility to infections.
Medications Metabolized by Cytochrome P450 Enzymes: Humira may influence the metabolism of drugs processed by CYP450 enzymes, potentially affecting their efficacy or safety. Monitoring and possible dose adjustments of these medications may be necessary.
Always inform your healthcare provider about all medications and supplements you're taking before starting Humira. This ensures a comprehensive evaluation of potential interactions and the development of a safe and effective treatment plan tailored to your needs.
How much does the HUMIRA starter pack cost?
The cost of the HUMIRA starter pack can vary significantly based on factors such as insurance coverage, pharmacy location, and any available discounts or assistance programs. Without insurance, the price can be quite high, often exceeding several thousand dollars. Patients are encouraged to check with their insurance provider and explore patient assistance programs offered by the manufacturer to potentially reduce out-of-pocket costs.
What is the most common side effect of HUMIRA?
The most common side effect of HUMIRA (adalimumab) is injection site reactions, which can include redness, itching, pain, or swelling at the site of the injection.
How to get HUMIRA for free?
There are several options for obtaining HUMIRA at a reduced cost or for free. Patients may consider the following:1. Patient Assistance Programs: AbbVie, the manufacturer of HUMIRA, offers a patient assistance program called "myAbbVie Assist" for eligible patients who are uninsured or underinsured. This program may provide HUMIRA at no cost to those who qualify.2. Insurance Coverage: Patients should check with their insurance provider to understand their coverage options for HUMIRA. Some insurance plans may cover the medication fully or partially.3. Non-Profit Organizations: Organizations such as the Patient Access Network Foundation or the HealthWell Foundation may offer financial assistance to help cover the cost of HUMIRA for eligible patients.4. Healthcare Provider: Patients should discuss with their healthcare provider, who may have additional resources or suggestions for obtaining HUMIRA at a reduced cost.Eligibility for these programs typically depends on factors such as income, insurance status, and medical need. It is advisable for patients to contact these programs directly for more detailed information and to apply.
What are the neurological side effects of Humira?
Humira (adalimumab) can have neurological side effects, although they are relatively rare. These may include headaches, dizziness, and in some cases, demyelinating disorders such as multiple sclerosis-like symptoms. Patients experiencing any unusual neurological symptoms should contact their healthcare provider for further evaluation.
What is the success rate of HUMIRA for HS patients?
The success rate of HUMIRA (adalimumab) for patients with hidradenitis suppurativa (HS) varies, but clinical trials have shown that approximately 50% of patients achieve a significant reduction in the number of abscesses and inflammatory nodules after 12 weeks of treatment. Individual responses can vary, and it is important for patients to discuss their specific case with their healthcare provider.